WBC cells can grow uncontrollably in leukemia, the genetic form of blood cancer

 

Leukemia Therapeutics 

  Leukemia is a type of blood cancer caused by the uncontrolled growth of our body's WBC cells. Chronic leukemia is a myeloproliferative disorder characterized by chromosomal translocation. Chronic leukemia patients are more susceptible to bacterial infections, have thrombocytopenia and anemia, and may have an enlarged spleen, which causes pain on the left side. Chronic leukemia has a high incidence rate in men and is the second most common type of cancer in male adults. Women over the age of 50 are more likely to develop this chronic disease. Diagnosis of chronic leukemia is dependent on the phase of the infection, which can be chronic, increased, or blast, and includes chemotherapy, stem cell transplants, and biologic therapies.

  Certain chemotherapy medications, such as Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Chlorambucil, Procarbazine Prednisolone, Mustine, Vincristine, Etoposide, Cyclophosphamide, Gemcitabine, Cisplatin, and Cytarabine, have a long history of use. Immunotherapy, combination therapy, monoclonal antibodies, and steroids are effective treatments for acute lymphoblastic leukemia. Bone marrow tests, platelet counts, and WBC (white blood cell) differential counts can all be used to diagnose leukemia. Blood transfusions, immunotherapy, bone marrow transplantation, radiation therapy, and chemotherapy can all be used for Leukemia Therapeutics.

   Leukemia is a type of cancer that affects the white blood cells (WBC) in our bodies. White blood cells assist our bodies in fighting infections caused by harmful pathogens. The bone marrow is the site of RBC production (which transports oxygen throughout the body), WBC production (which fights infection), and platelet production (which helps in blood clotting). When we have leukemia, our bone marrow produces abnormal WBC. Furthermore, abnormal WBCs are unable to function normally, or the WBC loses its ability to fight infection. Artificial ionizing radiation, benzene and petrochemicals, alkylation chemotherapy agents, genetic predisposition, and electromagnetic energy are all factors in the etiology of leukemia. The most common cause of leukemia in humans is a combination of genetic predisposition and electromagnetic energy. Leukemia symptoms include a new lump or swollen gland in the neck or arm, frequent nosebleeds, bone pain, night sweats, and a high fever.

  Immature blood cells are present in the bone marrow during the disease process. Flu, weight loss, body ache, body pain, and skin spots are some of the symptoms that patients experience as a result of the disease. Chemotherapy, stem cell transplants, and biologic therapies are all used to treat acute leukemia.

Comments

Popular posts from this blog

Total Disc Replacement complete details Of Competitive Landscape Executive Summary Development in next decade

Dengue Vaccines development and progress towards vaccine has increased over the past few years

Non-Contact Torque Sensors Increase Fuel Economy, Improve Ride Comfort and Safety